by B2i | Feb 2, 2021 | Press Releases
JUPITER, FL / February 2, 2021 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs,...
by B2i | Jan 11, 2021 | Press Releases
JUPITER, FL / January 11, 2021 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs,...
by B2i | Dec 9, 2020 | Press Releases
JUPITER, FL / December 9, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate...
by B2i | Nov 12, 2020 | Press Releases
Six new and expanded animal and human health collaborations since Q2 2020 Expanded presence in the Asia Pacific Region Important progress and expanded animal efficacy data in COVID-19 vaccine and antibody programs ZAPI to conduct additional animal studies for...
by B2i | Oct 29, 2020 | Press Releases
JUPITER, FL / October 29, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower production costs and...
